Dark

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR

At Close

Jan 23, 2026 3:59:30 PM EST

0.9995USD+21.890%(+0.1795)328,347

1.00Bid 1.06Ask 0.0600Spread

Pre-market

Jan 22, 2026 8:28:30 AM EST

0.7809USD-4.768%(-0.0391)0

After-hours

Jan 23, 2026 4:43:30 PM EST

0.9800USD-1.951%(-0.0195)5,639

OverviewHistoricalExchangesShortsTrends

open chart

Market Cap

3.47M

Headquarters

Po Box 4143 14 Einstein Street, Ness Ziona, Israel

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Last Split

May 21, 20241for10reverse

SCNI Stats

Avg. Vol. 10 Day

26,497

Avg. Vol. 30 Day

44,029

Market Cap

3,467,878

Shares Out.

3,468,225

On/Off Exchange

35%/65%

6 Month Beta

1.64

1 Year Beta

0.40

2 Year Beta

0.68

3 Year Beta

0.76

52 Week Low

0.61

52 Week High

6.18

SMA50

0.92

SMA200

1.70

1 Week

+15.60%

1 Month

+31.22%

3 Month

-29.59%

6 Month

-55.76%

1 Year

-71.77%

2 Year

-81.48%

Profile

biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax's technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.

SCNI Stock Summary

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) stock price today is $0.9995, and today's volume is 328,347. SCNI is up 21.890% today. The 30 day average volume is 44,029. SCNI market cap is 3.47M with 3,468,225 shares outstanding.

.dark-mode .t2vWc1{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .t2vWc1{ color: #333333; background-color: white; border: 2px solid #333333; }SCNIScinai Immunotherapeutics Ltd.stock NASDAQ ADR

SCNI Stock Summary

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR